← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Housey Pharmaceutical Research Lab
Southfield, MI
$4,296,517
Total funding
5
Grants
Funding over time
peak $1M · FY2006–15$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,296,517 · 5
By mechanism
R44$3,637,555 · 1
R43$658,962 · 4
Investigators at Housey Pharmaceutical Research Lab
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
"Discovery and Development of Anti-Diabetic Drugs."$1,018,907
R44 · FY2011 · DK
"Discovery and Development of Anti-Diabetic Drugs."$975,307
R44 · FY2012 · DK
"Discovery and Development of Anti-Diabetic Drugs."$880,003
R44 · FY2013 · DK
Discovery and Development of Antidiabetic Drugs$476,311
R44 · FY2006 · DK
Discovery and Development of Antidiabetic Drugs$287,027
R44 · FY2007 · DK
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).$239,005
R43 · FY2015 · CA
Isolation and Characterization of Low Molecular Weight Compounds Derived from Plant Extracts that Activate the IRS-2 Dependent Insulin Signaling Cascade.$170,341
R43 · FY2015 · DK
Novel Inhibitors for the Treatment of Highly Drug-Resistant Chronic Myelogenous$149,616
R43 · FY2009 · CA
Discovery and development of Antidiabetic Drugs$100,000
R43 · FY2003 · DK